Skip to main content
. 2011 Jul 18;6(7):e22148. doi: 10.1371/journal.pone.0022148

Table 1. Sample Category Statistics.

Category Age Female Male Mutational Burden (%) WBC (×109/L) RBC (×109/L) Hb (g/dL) Ht (%) PLT (×109/L)
[0] [3.4∼9.2] [F 3500∼5000; M 4000∼5600] [F 10.9∼14.7; M 13.2∼17.1] [F 32.5∼44.7; M 38.6∼50.7] [14.8∼35.2]
PV 63±14 6 6 64±24 16±6 6330±1131 15±2 48±6 627±270
ET 63±10 9 5 12±14 7±2 4013±646 13±1 39±4 732±259
ET+ 65±11 6 2 21±13 7±1 4208±550 13±1 40±2 613±227
ET− 61±10 3 3 0±0 7±2 3753±722 13±2 37±5 891±222
Group 1 63±15 3 6 76±7 18±5 6634±1070 16±2 50±5 578±285
Group 2 65±11 9 2 22±13 8±3 4593±946 13±1 41±3 652±223
Group 3 61±10 3 3 0±0 7±2 3753±722 13±2 37±5 891±222
Control 48±8 4 7

Mean value and standard deviation of age, mutation burden, white blood cell count, red blood cell count, hemoglobin, hematocrit, and platelet count at the time of blood sampling are shown. Numbers of females and males are shown. The normal range of each test is indicated in the brackets with female (F) or male (M)-specific ranges if available. Categories based on disease are: PV for polycythemia vera; ET for total cases of essential thrombocythemia; ET+ for V617F-positive ET, ET− for V617F-negative ET; and control for healthy volunteers. Group 1, group 2, and group 3 represents cases with a V617F mutation burden 50%–100%, 1%–50%, and 0%–1%, respectively.